Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SZSE: 301246)
Health Care · Pharmaceuticals · CN
CN¥21.27
+1.87% today · +35.7% 1Y
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SZSE: 301246) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.25B.
Over the last twelve months the share price has gained 35.7%, trading between 13.97 and 35.58.
Tweenvest scores Hubei Hongyuan Pharmaceutical Technology Co., Ltd. across four factors: quality 70/100, value 63/100, growth 30/100, dividend 6/100. Its strongest factor is quality.
301246 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.25B
- Revenue (TTM)
- $320.34M
- P/E
- 33.18
- EPS
- 0.64
- Dividend yield
- 0.23%
- Beta (5Y)
- 1.01
- 52-week high
- CN¥35.58
- 52-week low
- CN¥13.97
- Avg volume (3M)
- —
- Shares outstanding
- 396.81M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.38 | +0.54% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.